Kapiteijn E, Kranenbarg E K, Steup W H, Taat C W, Rutten H J, Wiggers T, van Krieken J H, Hermans J, Leer J W, van de Velde C J
Department of Surgery, Leiden University Medical Center, The Netherlands.
Eur J Surg. 1999 May;165(5):410-20. doi: 10.1080/110241599750006613.
To document local recurrence in primary rectal cancer when standardised techniques of surgery, radiotherapy, and pathology are used, and to investigate whether the local recurrence rate after total mesorectal excision permits the omission of adjuvant short term preoperative radiotherapy.
Prospective randomised study.
Dutch (n = 80), English (n = 1), German (n = 1), Swedish (n = 9), and Swiss (n = 1) hospitals.
The first 500 randomised Dutch patients with primary rectal cancer.
Local recurrence, survival, operation-related factors, specific pathological tumour characteristics, short and long term morbidity, and quality of life.
Between January 1996 and April 1998, 871 Dutch and 94 other patients were randomised. Our feasibility analysis shows that cooperation between and within the participating disciplines goes well. With regard to the surgical part, this can be confirmed by the large number of operations attended by consultant surgeons (58%). The number of abdominoperineal resections appeared to be low (30%), as did the percentage of lateral margins involved (13%). The rate of adverse effects of radiotherapy was acceptable. Apart from a larger operative blood loss and a higher infective complication rate in the irradiated group, no significant differences were found with regard to morbidity and mortality between the randomised groups.
The accrual of our trial is going well and it is feasible; short term preoperative radiotherapy is safe even in combination with TME.
记录在采用标准化手术、放疗和病理学技术时原发性直肠癌的局部复发情况,并研究全直肠系膜切除术后的局部复发率是否允许省略辅助性短期术前放疗。
前瞻性随机研究。
荷兰(n = 80)、英国(n = 1)、德国(n = 1)、瑞典(n = 9)和瑞士(n = 1)的医院。
首批500例随机分组的荷兰原发性直肠癌患者。
局部复发、生存率、手术相关因素、特定病理肿瘤特征、短期和长期发病率以及生活质量。
1996年1月至1998年4月期间,871例荷兰患者和94例其他国家患者被随机分组。我们的可行性分析表明,参与学科之间以及学科内部的合作进展顺利。就手术部分而言,这可以通过顾问外科医生参与的大量手术(58%)得到证实。腹会阴联合切除术的数量似乎较低(30%),侧方切缘受累的百分比也是如此(13%)。放疗的不良反应发生率是可以接受的。除了放疗组手术失血量更大和感染并发症发生率更高外,随机分组之间在发病率和死亡率方面没有发现显著差异。
我们试验的病例招募进展顺利且可行;短期术前放疗即使与全直肠系膜切除术联合使用也是安全的。